Genetic variation in a HSA-LET-7 binding site in RAD52 is associated with breast cancer susceptibility

Carcinogenesis

Volumn 34, Issue 3, 2013, Pages 689-693

  Jiang, Yue ^a   Qin, Zhenzhen ^a   Hu, Zhibin ^a   Guan, Xiaoxiang ^b   Wang, Yanru ^b   He, Yisha ^a   Xue, Jialei ^c   Liu, Xiao'an ^c   Chen, Jiaping ^a   Dai, Juncheng ^a   Jin, Guangfu ^a   Ma, Hongxia ^a   Wang, Shui ^c   Shen, Hongbing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

ADULT; ALLELE; ARTICLE; BINDING SITE; BREAST CANCER; CANCER RISK; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RAD52 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; BINDING SITES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE; CHINA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; RAD52 DNA REPAIR AND RECOMBINATION PROTEIN; RISK; RNA INTERFERENCE;

EID: 84874764687     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs373     Document Type: Article

References (49)

1. Lichtenstein, P. et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85.
2. Peto, J. et al. (2000) High constant incidence in twins and other relatives of women with breast cancer. Nat. Genet., 26, 411-414.
3. Zhang, B. et al. (2011) Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol., 12, 477-488.
4. Varghese, J.S. et al. (2010) Genome-wide association studies in common cancers-what have we learnt? Curr. Opin. Genet. Dev., 20, 201-209.
5. Ghoussaini, M., et al. (2012) Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat. Genet., 44, 312-318.
6. Meister, G. et al. (2004) Mechanisms of gene silencing by double-stranded RNA. Nature, 431, 343-349.
7. Esquela-Kerscher, A. et al. (2006) Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
8. Spizzo, R. et al. (2009) SnapShot: microRNAs in cancer. Cell, 137, 586-e1.
9. Gregory, P.A. et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol., 10, 593-601.
10. Song, B. et al. (2010) MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J. Exp. Clin. Cancer Res., 29, 29.
11. Ryan, B.M. et al. (2010) Genetic variation in microRNA networks: the implications or cancer research. Nat. Rev. Cancer, 10, 389-402.
12. Duan, R. et al. (2007) Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum. Mol. Genet., 16, 1124-1131.
13. Hu, Z. et al. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest., 118, 2600-2608.
14. Hu, Z. et al. (2009) Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum. Mutat., 30, 79-84.
15. Xu, J. et al. (2009) Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum. Mutat., 30, 1231-1236.
16. Xing, J. et al. (2012) Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer. Cancer Epidemiol. Biomarkers Prev., 21, 217-227.
17. Yu, Z. et al. (2007) Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res., 35, 4535-4541.
18. Xiong, F. et al. (2011) Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res., 71, 5175-5181.
19. Song, F. et al. (2009) An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin. Cancer Res., 15, 6292-6300.
20. Zhang, W. et al. (2011) A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. Ann. Oncol., 22, 104-109.
21. Jiang, Y. et al. (2011) Genetic variants at 1p11.2 and breast cancer risk: a two-stage study in Chinese women. PLoS ONE, 6, e21563.
22. Dai, J. et al. (2012) Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women. Breast Cancer Res., 14, R17.
23. Yu, F. et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 131, 1109-1123.
24. Ma, L. et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol., 12, 247-256.
25. Iorio, M.V. et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res., 65, 7065-7070.
26. Yu, Z. et al. (2008) A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J. Cell Biol., 182, 509-517.
27. Yan, L.X. et al. (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA, 14, 2348-2360.
28. Valastyan, S. et al. (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell, 137, 1032-1046.
29. Kato, M. et al. (2009) The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene, 28, 2419-2424.
30. Varambally, S. et al. (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science, 322, 1695-1699.
31. Tavazoie, S.F. et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 451, 147-152.
32. Kondo, N. et al. (2008) miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res., 68, 5004-5008.
33. Di Leva, G. et al. (2010) MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J. Natl. Cancer Inst., 102, 706-721.
34. Huang, Q. et al. (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol., 10, 202-210.
35. Hiard, S. et al. (2010) Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates. Nucleic Acids Res., 38, D640-651.
36. Kruger, J. et al. (2006) RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res., 34(Web Server issue), W451-454.
37. Tchatchou, S. et al. (2009) A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis, 30, 59-64.
38. Saetrom, P. et al. (2009) A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res., 69, 7459-7465.
39. Lao, J.P. et al. (2008) Rad52 promotes postinvasion steps of meiotic doublestrand-break repair. Mol. Cell, 29, 517-524.
40. Danoy, P. et al. (2008) Variants in DNA double-strand break repair and DNA damage-response genes and susceptibility to lung and head and neck cancers. Int. J. Cancer, 123, 457-463.
41. Lee, K.M. et al. (2005) Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin. Cancer Res., 11, 4620-4626.
42. Park, M.S. et al. (1996) Physical interaction between human RAD52 and RPA is required for homologous recombination in mammalian cells. J. Biol. Chem., 271, 18996-19000.
43. Johnson, C.D. et al. (2007) The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res., 67, 7713-7722.
44. Sampson, V.B. et al. (2007) MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res., 67, 9762-9770.
45. Lee, Y.S. et al. (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev., 21, 1025-1030.
46. Warren, A.S., et al. Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis. Breast Cancer Res. Treat, 130, 975-980.
47. Parsa, P. et al. (2009) Effects of reproductive factors on risk of breast cancer: a literature review. Asian Pac. J. Cancer Prev., 10, 545-550.
48. Rajkumar, L. et al. (2001) Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc. Natl. Acad. Sci. U.S.A., 98, 11755-11759.
49. MacMahon, B. et al. (1970) Age at first birth and breast cancer risk. Bull. World Health Organ., 43, 209-221.